Dry Eye Disease

What a wild ride these last 10 years or so have been.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Richard L. Lindstrom, MD, overviews two dry eye products from Surface Ophthalmics.

Patients with dry eye disease have worse sleep quality and may be at greater risk for unhealthy sleep duration, although a causal relationship between dry eye and sleep disorder has not been established, according to a meta-analysis.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Eric D. Donnenfeld, MD, discusses his presentation on Lacrifill for the treatment of dry eye disease.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Nordic Pharma Eye Care U.S. president Philip Gioia and chief commercial officer Jai G. Parekh, MD, MBA, FAAO, discuss the launch of Lacrifill for dry eye disease.

More than half of all patients treated with glaucoma medications have ocular surface disease, which predominantly manifests as dry eye disease.

BOSTON — Despite the unpredictability that comes with new product launches and reimbursement issues, experts are hopeful about ophthalmic business prospects in 2024.

Patients with myopia may qualify for several refractive surgery options depending on their age, lifestyle, corneal health and expectations.

Nearly 5 months after the FDA did not approve reproxalap for dry eye, Aldeyra Therapeutics has announced a plan to resubmit a new drug application for the reactive aldehyde species modulator, according to a press release.

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Douglas Katsev, MD, and Julia Katsev Larson, OD, discuss the use of Miebo for dry eye disease.